The Australian biotech giant’s profits have taken a hit from Americans’ reluctance to get vaccinated, sending its shares downward. The Australian biotech giant’s profits have taken a hit from Americans’ reluctance to get vaccinated, sending its shares downward. Business / Companies Sydney Morning Herald – Business